Archive Newsletter

  1. 02.10.26 -- Which Advanced Modalities Are Built For Commercial Scale In 2026? 2/10/2026
    02/10/26
  2. 02.10.26 -- STREAM Edition: 2026 Regulatory Roadmap: Get Set Up For Success 2/10/2026
    02/10/26 Cell & Gene Newsletter
  3. 02.09.26 -- Strategies For Multi-Modal Success And Annex 1 Compliance 2/9/2026
    02/09/26 Cell & Gene Newsletter
  4. 02.09.26 -- A Deeper Look At Pharma's Structural Supply Chain Vulnerability 2/9/2026
    02/09/26 Cell & Gene Newsletter
  5. 02.06.26 -- New Podcast Episodes: Putting Pressure On CDMOs, BoB@JPM, Building Safer CRISPR Medicines For CVD 2/6/2026
    02/06/26 Cell & Gene Newsletter
  6. 02.06.26 -- Sales & Operations Planning For Small Teams: Aligning Clinical Supply 2/6/2026
    02/06/26
  7. 02.05.26 -- The 5-Layer Fix For AI Failure In Pharmaceutical Manufacturing 2/5/2026
    02/05/26
  8. 02.04.26 -- Balancing The Elements: Strategies For Resilient Clinical Research 2/4/2026
    02/04/26 Cell & Gene Newsletter
  9. 02.04.26 -- In Vivo's Biggest Threat — Comparison To Old Models 2/4/2026
    02/04/26
  10. 02.03.26 -- STREAM Edition: Data Governance And Regulations For AI Use In GMP With Peter Baker 2/3/2026

    02/03/26 Cell & Gene Newsletter